Crinetics Pharmaceuticals Retained Earnings (Accumulated Deficit) 2017-2024 | CRNX

Crinetics Pharmaceuticals retained earnings (accumulated deficit) for the quarter ending September 30, 2024 were $-0.872B, a 46.82% increase year-over-year.

  • Crinetics Pharmaceuticals retained earnings (accumulated deficit) for 2023 were $-0.654B, a 48.85% increase from 2022.
  • Crinetics Pharmaceuticals retained earnings (accumulated deficit) for 2022 were $-0.439B, a 59.55% increase from 2021.
  • Crinetics Pharmaceuticals retained earnings (accumulated deficit) for 2021 were $-0.275B, a 64.22% increase from 2020.

Crinetics Pharmaceuticals Retained Earnings (Accumulated Deficit) 2017-2024 | CRNX

  • Crinetics Pharmaceuticals retained earnings (accumulated deficit) for 2023 were $-0.654B, a 48.85% increase from 2022.
  • Crinetics Pharmaceuticals retained earnings (accumulated deficit) for 2022 were $-0.439B, a 59.55% increase from 2021.
  • Crinetics Pharmaceuticals retained earnings (accumulated deficit) for 2021 were $-0.275B, a 64.22% increase from 2020.